Skip to main content
Free AccessResponse to the Letter of the Editor by Storebø et al.

Check and Double Check – the Cochrane review by Storebo et al. (2015) is indeed flawed

Published Online:https://doi.org/10.1024/1422-4917/a000473

Literature

  • Banaschewski, T., Gerlach, M., Becker, K., Holtmann, M., Döpfner, M. & Romanos, M. (2016) Trust, but verify. The errors and misinterpretations in the Cochrane analysis by O. J. Storebo and colleagues on the efficacy and safety of methylphenidate for the treatment of children and adolescents with ADHD. Zeitschrift für Kinder und Jugendpsychiatrie und Psychotherapie. doi: 10.1024/1422-4917/a000433 First citation in articleLinkGoogle Scholar

  • Brown, R. T., Wynne, M. E. & Medenis, R. (1985). Methylphenidate and cognitive therapy: A comparison of treatment approaches with hyperactive boys. Journal of Abnormal Child Psychology, 13, 69–87. First citation in articleCrossref MedlineGoogle Scholar

  • Bloch, M. H., Panza, K. E., Landeros-Weisenberger, A. & Leckman, J. F. (2009). Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 48(9), 884–893. First citation in articleCrossref MedlineGoogle Scholar

  • Chan, E., Fogler, J. M. & Hammerness, P. G. (2016). Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review. JAMA: the Journal of the American Medical Association, 315(18), 1997–2008. http://doi.org/10.1001/jama.2016.5453. First citation in articleCrossref MedlineGoogle Scholar

  • Coghill, D., Banaschewski, T., Lecendreux, M., Soutullo, C., Johnson, M., Zuddas, A., … Squires, L. (2013) European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder. European Neuropsychopharmacology 23(10), . First citation in articleCrossref MedlineGoogle Scholar

  • Coghill, D. R., Rhodes, S. M. & Matthews, K. (2007) The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biological Psychiatry 62(9): 954–62. First citation in articleCrossref MedlineGoogle Scholar

  • Firestone, P., Kelly, M. J., Goodman, J. T. & Davey, J. (1981) Differential effects of parent training and stimulant medication with hyperactives: a progress report. Journal of the American Academy of Child and Adolescent Psychiatry, 20, 135–147. First citation in articleCrossrefGoogle Scholar

  • Greenhill, L., Kollins, S., Abikoff, H., McCracken, J., Riddle, M. & Swanson, J., et al. (2006). Efficacy and safety of immediate-release methylphenidate treatment for pre-schoolers with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1284–1293. First citation in articleCrossref MedlineGoogle Scholar

  • Hoekstra, P. J. & Buitelaar, J. K. (2016). Response to: The evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder is in fact flawed. European Child and Adolescent Psychiatry. http://doi.org/10.1007/s00787-016-0856-z. First citation in articleGoogle Scholar

  • Jensen, P. S., Arnold, L. E., Richters, J. E., Severe, J. B., Vereen, D. & Vitiello, B., et al. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073–1086. First citation in articleMedlineGoogle Scholar

  • Storebo, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M. & Holmskov, M., et al. (2015). Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database of Systematic Reviews, Issue 11. Art. No.: CD009885. DOI: 10.1002/14651858.CD009885.pub2. First citation in articleCrossref MedlineGoogle Scholar